Search research articles
Contact Us
Filters
Showing results (11-20 of 77) with videos related to
Page
of 8
Sort By:
The Journal of Biological Chemistry
|
January 25, 1989
Purification and characterization of human recombinant precursor interleukin 1 beta
D Hazuda, R L Webb, P Simon, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1992
Pharmacologic characterization of an endothelinA (ETA) receptor antagonist in conscious rats
M K Bazil, R W Lappe, R L Webb
The American Journal of Physiology
|
June 1, 1983
Evidence for a central role for vasopressin in cardiovascular regulation
K H Berecek, R L Webb, M J Brody
Acta Oto-Laryngologica. Supplementum
|
January 1, 1984
Clinical results using a multiple-channel cochlear prosthesis
R C Dowell, R L Webb, G M Clark
Journal of Cardiovascular Pharmacology
|
January 1, 1995
Effects of the ETB-selective antagonist IRL 2500 in conscious spontaneously hypertensive and Wistar-Kyoto rats
R L Webb, A E Navarrete, G M Ksander
The American Journal of Pathology
|
December 1, 1991
Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury
M F Prescott, R L Webb, M A Reidy
The American Journal of Physiology
|
November 1, 1985
Selective destruction of renal afferent versus efferent nerves in rats
R W Lappe, R L Webb, M J Brody
The Annals of Otology, Rhinology & Laryngology. Supplement
|
September 1, 1995
Surgical considerations for the placement of the new Cochlear Pty Limited micro-multiple-channel cochlear implant for research studies
G M Clark, B C Pyman, R L Webb
Cardiovascular Drug Reviews
|
April 21, 2001
Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition?
M E Cooper, R L Webb, M de Gasparo
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1991
Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands
R L Webb, B W Barclay, S C Graybill
Page
of 8
Search research articles
Search
Showing results (11-20 of 77) with videos related to
Sort By:
Page
of 8
The Journal of Biological Chemistry
|
January 25, 1989
Purification and characterization of human recombinant precursor interleukin 1 beta
D Hazuda, R L Webb, P Simon, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1992
Pharmacologic characterization of an endothelinA (ETA) receptor antagonist in conscious rats
M K Bazil, R W Lappe, R L Webb
The American Journal of Physiology
|
June 1, 1983
Evidence for a central role for vasopressin in cardiovascular regulation
K H Berecek, R L Webb, M J Brody
Acta Oto-Laryngologica. Supplementum
|
January 1, 1984
Clinical results using a multiple-channel cochlear prosthesis
R C Dowell, R L Webb, G M Clark
Journal of Cardiovascular Pharmacology
|
January 1, 1995
Effects of the ETB-selective antagonist IRL 2500 in conscious spontaneously hypertensive and Wistar-Kyoto rats
R L Webb, A E Navarrete, G M Ksander
The American Journal of Pathology
|
December 1, 1991
Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury
M F Prescott, R L Webb, M A Reidy
The American Journal of Physiology
|
November 1, 1985
Selective destruction of renal afferent versus efferent nerves in rats
R W Lappe, R L Webb, M J Brody
The Annals of Otology, Rhinology & Laryngology. Supplement
|
September 1, 1995
Surgical considerations for the placement of the new Cochlear Pty Limited micro-multiple-channel cochlear implant for research studies
G M Clark, B C Pyman, R L Webb
Cardiovascular Drug Reviews
|
April 21, 2001
Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition?
M E Cooper, R L Webb, M de Gasparo
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1991
Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands
R L Webb, B W Barclay, S C Graybill
Page
of 8